Results of General Meeting
230630 Results of General Meeting
Motor Neurone Disease Phase 1/2 Clinical Trial Update
MND Clinical Trial Update (final)
Commencement of Cohort 3 in Phase 1/2 MND Trial
Commencement-of-Cohort-3-in-Phase-12-MND-Trial
PharmAust MND Trial Interim Analysis PK Outcomes
PharmAust MND Trial Interim Analysis PK Outcomes
Managing A Pet Cancer Diagnosis Is Possible With Right Resources And Support
Managing a pet cancer diagnosis is possible with right resources and support
Notice of General Meeting
Notice of General Meeting 2023 (final)
Motor Neurone Disease Clinical Trial Update
Motor Neurone Disease Clinical Trial Update (final)
Progress update on Phase 1/2 MND interim analysis
Progress update on Phase 12 MND interim analysis (final)
Independent tests show MPL retains long-term shelf-life
12-month GMP Stability (final)
MPL has anti-cancer effects across multiple cancer types
MPL has anti-cancer effects across multiple cancer types (final)